Grant: Master's Award: Canada Graduate Scholarships
University of Toronto
$17,500.00
Mechanisms of Club Cell Apoptosis in Chronic Lung Allograft Dysfunction
FY 2023-24
Summary
While lung transplantation (LTx) is the only available treatment for many end-stage lung diseases, it has a poor outcome compared to other organ transplants, with an average survival of 5 years. Chronic lung allograft dysfunction (CLAD) is the main cause of post-LTx death, diagnosed as a significant decline in lung function. Both environmental and immune system related factors are believed to lead to CLAD development. Emerging research has shown club cell death is increased in CLAD patients, which are a specific cell type that lines the airway. However, it is not well understood what leads to club cell death in CLAD. We have recently identified a specific cell death pathway that is increased in the club cells of CLAD patients. Namely, the tumour necrosis factor associated inducing ligand (TRAIL) pathway. The goal of this project is to evaluate whether club cells die specifically through the TRAIL pathway, when grown in a dish. 15 CLAD and 15 stable patients, post second transplant, will be selected, and their cells will be obtained during routine examinations. We will stimulate the cells with TRAIL protein and examine if these cells have increased club cell death, compared to cells not given TRAIL. We will also examine if blocking the TRAIL pathway reduces club cell death. Lastly, we will use human lung tissue from 10 CLAD patients, in comparison to 10 healthy donor lungs, to evaluate if this mechanism in cells is also observed in lung tissue. This research will lead to a better understanding of factors that lead to CLAD development. Findings may also help guide diagnostic and therapeutic approaches, with the goal of improving long-term outcomes post LTx. Specifically, blocking the TRAIL pathway may be a feasible treatment option in LTx patients.
Department
Program
Master's Award: Canada Graduate Scholarships
Recipient
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
506288
Name
Sebben David
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Mechanisms of Club Cell Apoptosis in Chronic Lung Allograft Dysfunction
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Apoptosis; Cell Biology; Cell Culture; Cell Death; Chronic Lung Allograft Dysfunction (Clad); Club Cells; Graft Rejection; Immunology; Transplantation
Abstract
While lung transplantation (LTx) is the only available treatment for many end-stage lung diseases, it has a poor outcome compared to other organ transplants, with an average survival of 5 years. Chronic lung allograft dysfunction (CLAD) is the main cause of post-LTx death, diagnosed as a significant decline in lung function. Both environmental and immune system related factors are believed to lead to CLAD development. Emerging research has shown club cell death is increased in CLAD patients, which are a specific cell type that lines the airway. However, it is not well understood what leads to club cell death in CLAD. We have recently identified a specific cell death pathway that is increased in the club cells of CLAD patients. Namely, the tumour necrosis factor associated inducing ligand (TRAIL) pathway. The goal of this project is to evaluate whether club cells die specifically through the TRAIL pathway, when grown in a dish. 15 CLAD and 15 stable patients, post second transplant, will be selected, and their cells will be obtained during routine examinations. We will stimulate the cells with TRAIL protein and examine if these cells have increased club cell death, compared to cells not given TRAIL. We will also examine if blocking the TRAIL pathway reduces club cell death. Lastly, we will use human lung tissue from 10 CLAD patients, in comparison to 10 healthy donor lungs, to evaluate if this mechanism in cells is also observed in lung tissue. This research will lead to a better understanding of factors that lead to CLAD development. Findings may also help guide diagnostic and therapeutic approaches, with the goal of improving long-term outcomes post LTx. Specifically, blocking the TRAIL pathway may be a feasible treatment option in LTx patients.
Competitiondate
202312
Approvedterm2
1 yr 0 mth
Pinamesdelim
Sebben, David
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~